News
12 Health Care Stocks Moving In Monday's After-Market Session
25 Mar 24
Movers
HC Wainwright & Co. Initiates Coverage On Regenxbio with Buy Rating, Announces Price Target of $36
11 Mar 24
News, Price Target, Initiation, Analyst Ratings
This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO
8 Mar 24
Analyst Color, Biotech, News, Upgrades, Top Stories, Markets, Analyst Ratings, Trading Ideas, General
RBC Capital Upgrades Regenxbio to Outperform, Raises Price Target to $35
8 Mar 24
News, Upgrades, Price Target, Analyst Ratings
Barclays Maintains Overweight on Regenxbio, Raises Price Target to $55
7 Mar 24
News, Price Target, Analyst Ratings
REGENXBIO Prices Upsized Public Offering Of 4,565,260 Common Shares At $23/Share And 1,521,740 Pre-Funded Warrants At $22.9999/Warrant
7 Mar 24
News
REGENXBIO Announces Proposed $125M Public Offering Of Common Stock
6 Mar 24
News, Offerings
Leerink Partners Upgrades Regenxbio to Outperform
6 Mar 24
News, Upgrades, Analyst Ratings
Beyond The Numbers: 4 Analysts Discuss Regenxbio Stock
6 Mar 24
Analyst Ratings
Baird Maintains Outperform on Regenxbio, Raises Price Target to $39
6 Mar 24
News, Price Target, Analyst Ratings
REGENXBIO's Muscle Wasting Disorder Drug Shows Strength, Improved Motor Function, Stock Soars
5 Mar 24
Biotech, News, Health Care, Movers, Trading Ideas, General
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
5 Mar 24
Movers
Regenxbio Announces New Initial Efficacy Data From Affinity Duchenne Trial
5 Mar 24
News
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
1 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
1 Mar 24
News, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Wedbush Reiterates Neutral on Regenxbio, Maintains $21 Price Target
28 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Regenxbio: Q4 Earnings Insights
27 Feb 24
Earnings
Regenxbio Q4 2023 GAAP EPS $(1.43) Misses $(1.27) Estimate, Sales $22.21M Miss $34.00M Estimate
27 Feb 24
Earnings, Earnings Misses, News
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
A Preview Of Regenxbio's Earnings
26 Feb 24
Earnings
Press releases
REGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Days
27 Mar 24
Press Releases
REGENXBIO to Participate in Upcoming Investor Conferences
11 Mar 24
Press Releases
REGENXBIO Announces Pricing of Upsized Public Offering of Common Stock and Pre-funded Warrants
6 Mar 24
Offerings, Press Releases
REGENXBIO Announces Proposed Public Offering of Common Stock
6 Mar 24
Offerings, Press Releases
REGENXBIO ANNOUNCES NEW POSITIVE INITIAL EFFICACY DATA FROM AFFINITY DUCHENNE® TRIAL
5 Mar 24
Press Releases
REGENXBIO to Host Webcast Event to Discuss New Interim Clinical Data from the Phase I/II AFFINITY DUCHENNE® Trial
29 Feb 24
Press Releases
REGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
27 Feb 24
Earnings, Press Releases
REGENXBIO to Host Conference Call on February 27 to Discuss Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
21 Feb 24
Press Releases
REGENXBIO Announces Pivotal Trial of RGX-121 for the Treatment of MPS II Achieves Primary Endpoint
7 Feb 24
Press Releases
REGENXBIO Announces Completion of Enrollment in Cohort 2 and Additional Positive Interim Data in AFFINITY DUCHENNE® Trial
7 Feb 24
Press Releases
REGENXBIO Announces Presentations at the 20th Annual WORLDSymposium 2024
31 Jan 24
Press Releases
REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery
16 Jan 24
Press Releases
REGENXBIO Announces Presentation at the Hawaiian Eye and Retina 2024 Meeting
10 Jan 24
Press Releases
U.S. District Court Issues Decision on REGENXBIO and University of Pennsylvania NAV® Technology Patent Infringement Lawsuit
8 Jan 24
Press Releases